Immunotherapies are drug treatments that aim to enhance your own body’s immune system so that it can recognise and destroy cancer cells more effectively. By enhancing the immune system, it is very common for healthy parts of the body to be affected too. There are now a number of immunotherapy drugs available that may be offered to you. They are given via an intravenous drip, usually in hospital. Immunotherapies can be given as a single agent or as a combination of two of these drugs: Nivolumab and Ipilimumab. All of these treatments have been assessed and have been approved for use in the UK.
Single agent refers to drugs that are administered to patients as individual treatments, as opposed to combinations of more than one drug.
Your doctor will discuss with you the probabilities of treatments working and the potential.
All cancer drug therapies are associated with some side effects that may impact on daily life to a lesser or greater extent. As immunotherapy treatment affects the immune system, this may cause inflammation in different parts of the body which can cause serious . They could happen during treatment, or some months after treatment has finished. In some people, these could be life-long and can occasionally be life-threatening. You may be affected by one or more side-effect. Generally, many can be dealt with if treated promptly. Below includes some of the common of these drugs: